SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pfizer accepts resignation of directors

29 Jun 2012 Evaluate
Pfizer has informed that the board of directors of the company at its meeting held on June 28, 2012, has accepted the resignation of Kewal Handa as the director and managing director of the company with effect from the end of day on August 15, 2012, Kewal Handa would continue as an employee of the company until his retirement from the company i.e. August 31, 2012.

Further, the board at its meeting held on June 28, 2012 appointed Aijaz Tobaccowalla as additional director and managing director of the company with effect from August 16, 2012 subject to approval of shareholders and central government.

The above information is a part of company's filings submitted to BSE.

Pfizer Share Price

4794.05 -17.00 (-0.35%)
11-May-2026 09:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.45
Dr. Reddys Lab 1275.00
Cipla 1333.20
Zydus Lifesciences 932.75
Lupin 2237.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×